What is the Cohance Lifesciences Ltd FII shareholding?

Foreign Institutional Investors (FIIs) hold 7.71% of the total equity shares of Cohance Lifesciences Ltd.

What is the Cohance Lifesciences Ltd DII shareholding?

Domestic Institutional Investors (DIIs) hold 18.86% of the total equity shares of Cohance Lifesciences Ltd.

How has the Cohance Lifesciences Ltd promoter holding changed?

The promoter holding in Cohance Lifesciences Ltd changed from 57.49% to 57.48% during the latest reported period.

How has the Cohance Lifesciences Ltd FII holding changed?

The FII holding in Cohance Lifesciences Ltd changed from 6.50% to 7.71% during the latest reported period.

How has the Cohance Lifesciences Ltd DII holding changed?

The DII holding in Cohance Lifesciences Ltd changed from 20.09% to 18.86% during the latest reported period.

Who are the major shareholders of Cohance Lifesciences Ltd?

The major shareholders of Cohance Lifesciences Ltd may include promoters, institutional investors and other significant shareholders holding substantial equity stakes.

Cohance Lifesciences Ltd Shareholding Pattern: Promoters, FII, DII & Public

Q: What is the Cohance Lifesciences Ltd public shareholding?

Public shareholders hold 15.95% of the total equity shares of Cohance Lifesciences Ltd as per the latest available data.

Cohance Lifesciences Ltd Share Price

Detail Overview

Pharmaceuticals - Indian - Bulk Drugs & Formln M/SNSE

₹449.85

-4.00(-0.88%)

As on 23 Oct 2026 at 15:58

As of 23 Oct 2026 at 15:58, Cohance Lifesciences Ltd is trading at ₹449.85. The 52-week range stands at ₹266.70–₹903.40, with a market cap of ₹17.17 thousand crore. At a P/E of 89.73 and a dividend yield of 0.00%, it is a mid-cap stock in the Pharmaceuticals sector.